Rapid and Accurate Detection of <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> Strains Susceptible/Resistant to Cotrimoxazole through Evaluation of Cell Elongation

• Main Authors: Isidoro López, Fátima Otero, Rebeca Guillén, María del Carmen Fernández, Germán Bou, Jaime Gosálvez, José Luis Fernández
• Format: Article
• Language: English
• Published: MDPI AG 2021-06-01
• Series: Antibiotics
• Subjects: cotrimoxazole; trimethoprim-sulfamethoxazole; antibiotic resistance; cell length; rapid assay; Gram-negative
• Online Access: https://www.mdpi.com/2079-6382/10/6/720

Trimethoprim-sulfamethoxazole is a well-known antibiotic that inhibits folic acid synthesis, a topic of renewed interest. Since resistant strains are increasingly more common, an early and accurate discrimination of susceptibility may assure confident therapy. Two morphological assays were performed in <i>Escherichia coli</i> (<i>n</i> = 50; 27 non-susceptible) and <i>Klebsiella pneumoniae</i> (<i>n</i> = 52; 18 non-susceptible). First, the strains were incubated with the CLSI breakpoint of cotrimoxazole for 150 min, which induced cell lengthening in the susceptible strains. Second, the bacteria were incubated with mitomycin C (MMC) (0.5 mg/L) for 120 min to induce a SOS-linked cell enlargement higher than that obtained by cotrimoxazole alone. When cotrimoxazole was added 30 min before MMC, the inhibition of folic acid synthesis in the susceptible strain resulted in the suppression of MMC-induced extra elongation. In the non-susceptible strains, folic acid synthesis continued despite the antibiotic, so that the MMC-induced extra cell lengthening could not be impeded. Whereas the first assay resulted in five false negatives and four false positives of resistance, the results of the second assay matched those of the conventional antibiogram. This simple morphological procedure is performed in 2 h and 45 min and may allow a rapid selection of useful and relatively inexpensive therapy, thereby preserving the newer broad-spectrum antibiotics.